Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127023041 | 12702304 | 1 | I | 20160824 | 20160831 | 20160831 | EXP | US-ALEXION PHARMACEUTICALS INC-A201606433 | ALEXION | 26.00 | YR | M | Y | 0.00000 | 20160831 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127023041 | 12702304 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | U | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | |||||
| 127023041 | 12702304 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | UNK UNK, Q2W | U | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||||
| 127023041 | 12702304 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | U | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | |||||
| 127023041 | 12702304 | 4 | C | CEFTRIAXONE. | CEFTRIAXONE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127023041 | 12702304 | 1 | Haemolytic uraemic syndrome |
| 127023041 | 12702304 | 4 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127023041 | 12702304 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127023041 | 12702304 | Abdominal pain | |
| 127023041 | 12702304 | Blood lactate dehydrogenase increased | |
| 127023041 | 12702304 | Glomerular filtration rate decreased | |
| 127023041 | 12702304 | Haptoglobin decreased | |
| 127023041 | 12702304 | Inappropriate schedule of drug administration | |
| 127023041 | 12702304 | Platelet count decreased | |
| 127023041 | 12702304 | Renal impairment | |
| 127023041 | 12702304 | Urine analysis abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |